Dr. Steven Kirshblum, MD
Claim this profileKessler Institute for Rehabilitation
Affiliated Hospitals
Kessler Institute For Rehabilitation
Kessler Foundation
Clinical Trials Steven Kirshblum, MD is currently running
Romosozumab + Denosumab
for Spinal Cord Injury
The objective of the proposed work is to determine whether administration for 12 months of romosozumab (evenity) followed by 12 months of denosumab (prolia) will maintain bone mass at the knee in subjects with chronic SCI.
Recruiting
3 awards
Phase 4
5 criteria
Spinal Stimulation
for Spinal Cord Injury
The goal of this clinical trial is to evaluate the effect of transcutaneous spinal cord stimulation on blood pressure in individuals with an acute spinal cord injury (within 30 days of injury). Blood pressure instability, specifically orthostatic hypotension (a drop in blood pressure when moving lying flat on your back to an upright position), appears early after the injury and often significantly interferes with participation in the critical rehabilitation time period. The main questions it aims to answer are: 1. Can optimal spinal stimulation increase blood pressure and resolve orthostatic symptoms (such as dizziness and nausea) when individuals undergo an orthostatic provocation (a sit-up test)? Optimal stimulation and sham stimulation (which is similar to a placebo treatment) will be compared. 2. What are the various spinal sites and stimulation parameters that can be used to increase and stabilize blood pressure to the normal range of 110-120 mmHg? Participants will undergo orthostatic tests (lying on a bed that starts out flat and then moved into an upright seated position by raising the head of bed by 90° and dropping the base of the bed by 90° from the knee) with optimal and sham stimulation, and their blood pressure measurements will be evaluated and compared.
Recruiting
0 awards
N/A
4 criteria
More about Steven Kirshblum, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Steven Kirshblum, MD has experience with
- Denosumab
- Romosozumab
- Romoszumab
- BQ 2.0
- Whole Body Vibration
- Mirabegron
Breakdown of trials Steven Kirshblum, MD has run
Spinal Cord Injury
Osteoporosis
Muscle Spasticity
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Kirshblum, MD specialize in?
Steven Kirshblum, MD focuses on Spinal Cord Injury and Osteoporosis. In particular, much of their work with Spinal Cord Injury has involved treating patients, or patients who are undergoing treatment.
Is Steven Kirshblum, MD currently recruiting for clinical trials?
Yes, Steven Kirshblum, MD is currently recruiting for 3 clinical trials in West Orange New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Steven Kirshblum, MD has studied deeply?
Yes, Steven Kirshblum, MD has studied treatments such as Denosumab, Romosozumab, Romoszumab.
What is the best way to schedule an appointment with Steven Kirshblum, MD?
Apply for one of the trials that Steven Kirshblum, MD is conducting.
What is the office address of Steven Kirshblum, MD?
The office of Steven Kirshblum, MD is located at: Kessler Institute for Rehabilitation, West Orange, New Jersey 07052 United States. This is the address for their practice at the Kessler Institute for Rehabilitation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.